A Philadelphia jury has slapped Johnson & Johnson with a $70 million verdict after finding that its antipsychotic drug Risperdal caused an adolescent boy to develop female breasts, leading some to speculate whether the pharmaceutical giant may be ready to settle the more than 1,700 Risperdal side effects lawsuits pending in Philadelphia. The staggering verdict in the fifth Risperdal case to go to trial is the fourth win for plaintiffs but it vastly overshadows the other jury awards, which total $4.75 million. The lawsuits allege that Johnson & Johnson and its subsidiary Janssen Pharmaceuticals withheld side effects data with Risperdal, ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.